The International Bone Research Association (IBRA) is an independent non-profit organization driving specific concepts from Basic, Moderate, Advanced and Expert levels for Medical and Surgical Education world wide. We are proud to work with excellent partners such as:
Medartis is committed to providing surgeons and operating room personnel in cranio-maxillofacial surgery, hand and plastic surgery as well as orthopaedic surgery with innovative implants, instruments and services that represent advances in osteosynthesis and thus a patient’s quality of life.
With a proven history in the fields of metallurgy, osteosynthesis and clinical device technology, Medartis develops, produces and distributes its products worldwide.
Medartis’ newly developed products are scientifically proven and clinically evaluated.
The common goal of the partnership with IBRA is to offer scientifically founded treatment solutions and high-quality products along with first class service. Educational courses and workshops in the field of bone reconstruction will be the foundation for future patient treatments.
Aesculap, a product brand in the B. Braun portfolio, is a partner for surgical and interventional treatment concepts in inpatient and ambulatory care. As one of the world's leading medical technology companies, B. Braun protects and improves the health of people around the world. For over 180 years, the family-owned company has been accelerating progress in health care with pioneering spirit and groundbreaking contributions. This innovative strength continues to be the foundation of B. Braun's success today—always with the goal of improving clinical outcomes, cost of care and patient benefits.
More than 65,000 employees live Sharing Expertise worldwide, they make B. Braun a true partner that develops smart solutions and sets new standards. By linking products, services and consulting, the company improves treatment processes and supports medical staff. In doing so, B. Braun always acts with future generations in mind, which is why responsibility for sustainable growth is embedded into all business processes. In 2022, the B. Braun Group generated sales of € 8.5 billion.